Skip to content
10-K

Annual Report

Akebia Therapeutics, Inc. AKBA

0001517022-26-000020

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 267.88M sh
Shares Diluted FY 2025 · Dec 31, 2025 257.16M sh
Shares Diluted FY 2025 · Dec 31, 2024 210.95M sh
Shares Diluted FY 2025 · Dec 31, 2023 187.47M sh
Capex FY 2025 · Dec 31, 2025 $291K
Capex FY 2025 · Dec 31, 2024 $33K
Capex FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 $67.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$40.66M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$23.38M
Long Term Debt FY 2025 · Dec 31, 2025 $48.25M
Long Term Debt FY 2025 · Dec 31, 2024 $38.69M
Cash And Equivalents FY 2025 · Dec 31, 2025 $184.84M
Cash And Equivalents FY 2025 · Dec 31, 2024 $51.87M
Cash And Equivalents FY 2025 · Dec 31, 2023 $42.93M
Stockholders Equity FY 2025 · Dec 31, 2025 $32.61M
Stockholders Equity FY 2025 · Dec 31, 2024 −$49.19M
Stockholders Equity FY 2025 · Dec 31, 2023 −$30.58M
Current Liabilities FY 2025 · Dec 31, 2025 $162.94M
Current Liabilities FY 2025 · Dec 31, 2024 $80.91M
Total Liabilities FY 2025 · Dec 31, 2025 $343.96M
Total Liabilities FY 2025 · Dec 31, 2024 $269.86M
Current Assets FY 2025 · Dec 31, 2025 $252.96M
Current Assets FY 2025 · Dec 31, 2024 $113.83M
Total Assets FY 2025 · Dec 31, 2025 $376.57M
Total Assets FY 2025 · Dec 31, 2024 $220.67M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.02
Eps Diluted FY 2025 · Dec 31, 2024 −$0.33
Eps Diluted FY 2025 · Dec 31, 2023 −$0.28
Eps Basic FY 2025 · Dec 31, 2025 −$0.02
Eps Basic FY 2025 · Dec 31, 2024 −$0.33
Eps Basic FY 2025 · Dec 31, 2023 −$0.28
Sga Expense FY 2025 · Dec 31, 2025 $107.48M
Sga Expense FY 2025 · Dec 31, 2024 $106.55M
Sga Expense FY 2025 · Dec 31, 2023 $100.23M
Rd Expense FY 2025 · Dec 31, 2025 $62.36M
Rd Expense FY 2025 · Dec 31, 2024 $37.65M
Rd Expense FY 2025 · Dec 31, 2023 $63.08M
Net Income FY 2025 · Dec 31, 2025 −$5.35M
Net Income FY 2025 · Dec 31, 2024 −$69.41M
Net Income FY 2025 · Dec 31, 2023 −$51.93M
Operating Income FY 2025 · Dec 31, 2025 $23.5M
Operating Income FY 2025 · Dec 31, 2024 −$50.47M
Operating Income FY 2025 · Dec 31, 2023 −$46.26M
Cost Of Revenue FY 2025 · Dec 31, 2025 $39.46M
Cost Of Revenue FY 2025 · Dec 31, 2024 $63.18M
Cost Of Revenue FY 2025 · Dec 31, 2023 $74.15M
Revenue FY 2025 · Dec 31, 2025 $236.2M
Revenue FY 2025 · Dec 31, 2024 $160.18M
Revenue FY 2025 · Dec 31, 2023 $194.62M